1 / 11

Live Donor Registry

Live Donor Registry. Steve Chadban. Transplant numbers. Impaired kidney function. Calculated GFR (body surface area adjusted) Median and interquartile range. Prevalence of abnormal glucose metabolism* in Australian Adults, AusDiab 1999-2000.

gustav
Download Presentation

Live Donor Registry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Live Donor Registry Steve Chadban

  2. Transplant numbers

  3. Impaired kidney function Calculated GFR (body surface area adjusted) Median and interquartile range

  4. Prevalence of abnormal glucose metabolism* in Australian Adults, AusDiab 1999-2000. *WHO criteria after OGTT Dunstan etal. Diabetes Care 2002;25:829-34

  5. Patients who have undergone unilateral nephrectomy who are obese: Praga et al. KI 2000;58:2111

  6. Risk of ESKD after kidney donation - USA • Kidney donors on waiting list 0.15% • Incidence • white < 50 0.04% • Black <50 0.2% • Significantly greater than risk in age matched pop gen pop donor • White 30-39 0.008 0.1 • Black 0.04 0.52 • Cause of ESRF • FSGS • DM • 20-50% have a family Hx of DM • Age at donation 38.5y • Age at ESRF 49 Connie Davis, ATC 2005

  7. Pre-donation data • Commenced 2004, data 2004-6 = 764 (>95%) • Age 48+/-11yrs, 25%>57, 18%>60 • F 56%, M 44%, 89% caucasian • 62% related, 22%spousal, 15% other LURD • SCr 78+/-15 umol/L, 25%>88 • GFR 112 +/-30, GFR<96 in 25% • Nuc GFR (n=329) 117+/-23, 25% <100, 2%<80 • MDRD or CrCl (n=250) 107 +/-36, 25%<76, 29%<80

  8. Pre-donation data • SCr 78+/-15 umol/L, 25%>88 • GFR 112 +/-30, GFR<96 in 25% • Nuc GFR (n=329) 117+/-23, 25% <100, 2%<80 • MDRD or CrCl (n=250) 107 +/-36, 25%<76, 29%<80 • Proteinuria (n=627 or 82%) • Mean 0.12g/day • >0.20g/d in 21 (3.3%)

  9. Pre-donation data • BMI 26 +/-4.0 – 16% 30-35, 2.3% > 35 • Diabetes – known (10) + OGTT (14) = 24 (3%) • OGTT reported 70%, 81% normal, 17% IFG, 2% DM • +FHx in 21% • 2 diabetic donors with BP>140/90 • BP 125/75 +/- 13/9 • Systolic BP >140 in 6%, DBP >90 in 2.7%, >140/90 in 1.6% • Smoking – 8.3%

  10. Follow-up post-nephrectomy • 1 year = 23%, 2 year = 15% • 1yr follow-up (n=235): • SBP 124±13 • DBP 75±8 • New hypertension 10% • SCr 108±23 • MDRD 59±12 – 25% <51 • PCR (n=75) 5.6±5.5 • Reported problems (n) – elevated SCr (6), proteinuria (3), pain (1), IgA (1), retroperitoneal fibrosis (1).

  11. Key Issues Follow-up – non-mandated but crucial! • Current follow-up data not useful • Frequency of ESKD among donors, mortality • Outcomes at extremes of GFR • Hyperfiltration – GFR>140 with low-grade proteinuria • Low baseline GFR – typically elderly, impact on CVS outcomes • Proteinuria – development, evolution, relationship to BMI, diabetes • BP – kidney, CVS and BP outcomes among hypertensives, smokers • Controls

More Related